VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

Stock Comparison

WuXi AppTec Co., Ltd. vs Agilent Technologies, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

WuXi AppTec Co., Ltd.

603259 · Shanghai Stock Exchange

Market cap (USD)$37.4B
Gross margin (TTM)49.2%
Operating margin (TTM)42.7%
Net margin (TTM)41.7%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryCN
Data as of2026-05-01
Moat score
72/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into WuXi AppTec Co., Ltd.'s moat claims, evidence, and risks.

View 603259 analysis

Agilent Technologies, Inc.

A · New York Stock Exchange

Market cap (USD)$32.7B
Gross margin (TTM)52.2%
Operating margin (TTM)20.6%
Net margin (TTM)18.3%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
Data as of2025-12-22
Moat score
65/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Agilent Technologies, Inc.'s moat claims, evidence, and risks.

View A analysis

Comparison highlights

  • Moat score gap: WuXi AppTec Co., Ltd. leads (72 / 100 vs 65 / 100 for Agilent Technologies, Inc.).
  • Segment focus: WuXi AppTec Co., Ltd. has 3 segments (84% in WuXi Chemistry); Agilent Technologies, Inc. has 3 segments (41.9% in Agilent CrossLab).
  • Primary market structure: Competitive vs Competitive. Pricing power: Moderate vs Strong.
  • Moat breadth: WuXi AppTec Co., Ltd. has 5 moat types across 3 domains; Agilent Technologies, Inc. has 5 across 2.

Primary market context

WuXi AppTec Co., Ltd.

WuXi Chemistry

Market

Global synthetic-molecule CRDMO services, including small-molecule discovery, process development, API manufacturing, peptides and oligonucleotides

Geography

Global, with major customer exposure to the United States, Europe and China

Customer

Large pharmaceutical companies, emerging biotechs and virtual pharma companies

Role

Integrated contract research, development and manufacturing partner across discovery, development and commercial manufacturing

Revenue share

84%

Agilent Technologies, Inc.

Agilent CrossLab

Market

Laboratory services, compliance/maintenance, consumables and lab informatics across the lab workflow

Geography

Global

Customer

B2B (installed base labs across pharma, diagnostics, academia and applied markets)

Role

Aftermarket services + consumables + informatics

Revenue share

41.9%

Side-by-side metrics

WuXi AppTec Co., Ltd.
Agilent Technologies, Inc.
Ticker / Exchange
603259 - Shanghai Stock Exchange
A - New York Stock Exchange
Market cap (USD)
$37.4B
$32.7B
Gross margin (TTM)
49.2%
52.2%
Operating margin (TTM)
42.7%
20.6%
Net margin (TTM)
41.7%
18.3%
Sector
Healthcare
Healthcare
Industry
Medical - Diagnostics & Research
Medical - Diagnostics & Research
HQ country
CN
US
Primary segment
WuXi Chemistry
Agilent CrossLab
Market structure
Competitive
Competitive
Market share
6%-9% (implied)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Strong
Moat score
72 / 100
65 / 100
Moat domains
Supply, Demand, Legal
Demand, Supply
Last update
2026-05-01
2025-12-22

Moat coverage

Shared moat types

Design In Qualification

WuXi AppTec Co., Ltd. strengths

Scope EconomiesCapacity MoatCompliance AdvantageOperational Excellence

Agilent Technologies, Inc. strengths

Installed Base ConsumablesBrand TrustService Field NetworkData Workflow Lockin

Segment mix

WuXi AppTec Co., Ltd. segments

Full profile >

WuXi Chemistry

Competitive

84%

WuXi Testing

Competitive

9.3%

WuXi Biology

Competitive

6.2%

Agilent Technologies, Inc. segments

Full profile >

Life Sciences and Diagnostics Markets

Oligopoly

39.2%

Agilent CrossLab

Competitive

41.9%

Applied Markets

Oligopoly

18.9%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.